These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 32196834)
1. TFPI2 and NDRG4 gene promoter methylation analysis in peripheral blood mononuclear cells are novel epigenetic noninvasive biomarkers for colorectal cancer diagnosis. Bagheri H; Mosallaei M; Bagherpour B; Khosravi S; Salehi AR; Salehi R J Gene Med; 2020 Aug; 22(8):e3189. PubMed ID: 32196834 [TBL] [Abstract][Full Text] [Related]
2. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783 [TBL] [Abstract][Full Text] [Related]
3. Field Cancerization in Sporadic Colon Cancer. Park SK; Song CS; Yang HJ; Jung YS; Choi KY; Koo DH; Kim KE; Jeong KU; Kim HO; Kim H; Chun HK; Park DI Gut Liver; 2016 Sep; 10(5):773-80. PubMed ID: 27114416 [TBL] [Abstract][Full Text] [Related]
4. Differential methylation of DNA promoter sequences in peripheral blood mononuclear cells as promising diagnostic biomarkers for colorectal cancer. Mosallaei M; Siri G; Alani B; Khomartash MS; Naghoosi H; Pourghazi F; Heidari R; Sabet MN; Behroozi J J Cancer Res Ther; 2024 Apr; 20(3):993-998. PubMed ID: 39023608 [TBL] [Abstract][Full Text] [Related]
5. A systematic review and quantitative assessment of methylation biomarkers in fecal DNA and colorectal cancer and its precursor, colorectal adenoma. Liu R; Su X; Long Y; Zhou D; Zhang X; Ye Z; Ma J; Tang T; Wang F; He C Mutat Res Rev Mutat Res; 2019; 779():45-57. PubMed ID: 31097151 [TBL] [Abstract][Full Text] [Related]
6. Significance of SDC2 and NDRG4 methylation in stool for colorectal cancer diagnosis. Long L; Sun Q; Yang F; Zhou H; Wang Y; Xiao C; He Q; Yi B Clin Biochem; 2024 Feb; 124():110717. PubMed ID: 38224931 [TBL] [Abstract][Full Text] [Related]
7. Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Glöckner SC; Dhir M; Yi JM; McGarvey KE; Van Neste L; Louwagie J; Chan TA; Kleeberger W; de Bruïne AP; Smits KM; Khalid-de Bakker CA; Jonkers DM; Stockbrügger RW; Meijer GA; Oort FA; Iacobuzio-Donahue C; Bierau K; Herman JG; Baylin SB; Van Engeland M; Schuebel KE; Ahuja N Cancer Res; 2009 Jun; 69(11):4691-9. PubMed ID: 19435926 [TBL] [Abstract][Full Text] [Related]
8. Evaluating the clinical performance of Zhang K; He Q; Cao Q; Chuan J; Qin A; Tang L; Zhang X; Xiao C; Zhu B; Hu M; Chang L; Bu ZX; Fu L; Yang T; Wang Y; Liu W Epigenomics; 2024 Jan; 16(2):93-108. PubMed ID: 38226561 [TBL] [Abstract][Full Text] [Related]
9. Stool DNA methylation assays in colorectal cancer screening. Kadiyska T; Nossikoff A World J Gastroenterol; 2015 Sep; 21(35):10057-61. PubMed ID: 26401070 [TBL] [Abstract][Full Text] [Related]
10. Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC. Rademakers G; Massen M; Koch A; Draht MX; Buekers N; Wouters KAD; Vaes N; De Meyer T; Carvalho B; Meijer GA; Herman JG; Smits KM; van Engeland M; Melotte V Clin Epigenetics; 2021 Apr; 13(1):80. PubMed ID: 33858496 [TBL] [Abstract][Full Text] [Related]
11. Promoter methylation of matrix metallopeptidase 9 in peripheral blood mononuclear cells: A novel biomarker in a promising source for noninvasive colorectal cancer diagnosis. Shaygannejad A; Sohrabi B; Rad SR; Yousefisadr F; Darvish H; Soosanabadi M J Cancer Res Ther; 2023 Oct; 19(7):1797-1802. PubMed ID: 38376281 [TBL] [Abstract][Full Text] [Related]
12. Progressive alteration of DNA methylation of Alu, MGMT, MINT2, and TFPI2 genes in colonic mucosa during colorectal cancer development. Kang B; Lee HS; Jeon SW; Park SY; Choi GS; Lee WK; Heo S; Lee DH; Kim DS Cancer Biomark; 2021; 32(2):231-236. PubMed ID: 34092617 [TBL] [Abstract][Full Text] [Related]
13. Analysis of Siri G; Alesaeidi S; Dizghandi SE; Alani B; Mosallaei M; Soosanabadi M J Cancer Res Ther; 2022 Dec; 18(Supplement):S354-S358. PubMed ID: 36510988 [TBL] [Abstract][Full Text] [Related]
14. Quantitative detection of SRY-Box 21 ( Moradi K; Babaei E; Hosseinpour Feizi MA; Safaralizadeh R; Rezvani N Indian J Cancer; 2021; 58(2):217-224. PubMed ID: 33402569 [TBL] [Abstract][Full Text] [Related]
15. Is methylation analysis of Park SK; Baek HL; Yu J; Kim JY; Yang HJ; Jung YS; Choi KY; Kim H; Kim HO; Jeong KU; Chun HK; Kim K; Park DI Intest Res; 2017 Oct; 15(4):495-501. PubMed ID: 29142517 [TBL] [Abstract][Full Text] [Related]
16. NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population. Chen X; Yang Y; Liu J; Li B; Xu Y; Li C; Xu Q; Liu G; Chen Y; Ying J; Duan S Oncotarget; 2017 Jan; 8(5):8105-8119. PubMed ID: 28042954 [TBL] [Abstract][Full Text] [Related]
17. Highly sensitive fecal DNA testing of NDRG4 12b methylation is a promising marker for detection of colorectal precancerosis. Ji X; Sha J; Qian H; Zhang G; He T; Dang Y J BUON; 2021; 26(4):1239-1245. PubMed ID: 34564976 [TBL] [Abstract][Full Text] [Related]
18. The importance of stool DNA methylation in colorectal cancer diagnosis: A meta-analysis. Mojtabanezhad Shariatpanahi A; Yassi M; Nouraie M; Sahebkar A; Varshoee Tabrizi F; Kerachian MA PLoS One; 2018; 13(7):e0200735. PubMed ID: 30024936 [TBL] [Abstract][Full Text] [Related]
19. A systematic evaluation of stool DNA preparation protocols for colorectal cancer screening via analysis of DNA methylation biomarkers. Jin S; Ye Q; Hong Y; Dai W; Zhang C; Liu W; Guo Y; Zhu D; Zhang Z; Chen S; Wang Y; Li D; Ma W; Yang Z; Li J; Zheng Z; Luan J; Wu X; Jiang F; Xu C; Ding C Clin Chem Lab Med; 2020 Jul; 59(1):91-99. PubMed ID: 32673280 [TBL] [Abstract][Full Text] [Related]
20. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma. Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]